Osteoporosis and determinants of bone density in patients with Crohn's disease.
about
Imiglucerase and its use for the treatment of Gaucher's diseaseLow serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?Improvement of lumbar bone mass after infliximab therapy in Crohn's disease patients.Bone mineral metabolism in pediatric inflammatory bowel disease.Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's diseaseRenal and Gastrointestinal Considerations in Joint Replacement Surgery.The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone lossInfluence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's diseaseHip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort studyThe major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis.Bone density and bone metabolism in patients with inflammatory bowel diseaseBone loss in Crohn's disease: exercise as a potential countermeasure.Skeletal morbidity in inflammatory bowel disease.Prevention and treatment of osteoporosis in inflammatory bowel disease.The early onset of disease may be a risk factor for decreased bone mineral density in patients with inflammatory bowel disease.Exercise and Crohn's disease: speculations on potential benefits.Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study.Nutritional management of Crohn's disease.Sex-Specific Issues in Inflammatory Bowel Disease.Bone loss in patients with the ileostomy and ileal pouch for inflammatory bowel disease.Bones in pediatric Crohn's disease: a review of fracture risk in children and adults.Paediatric inflammatory bowel disease: a mechanistic approach to investigate exclusive enteral nutrition treatment.Calcaneal ultrasound bone densitometry is not a useful tool to screen patients with inflammatory bowel disease at high risk for metabolic bone disease.The impact of smoking in Crohn's disease: no smoke without fire.Decreased trabecular bone mineral density in newly diagnosed inflammatory bowel disease patients in Korea.Clinical relevance of changes in bone metabolism in inflammatory bowel disease.The association between corticosteroid use and development of fractures among IBD patients in a population-based database.Risk factors for osteoporosis in Crohn's disease: infliximab, corticosteroids, body mass index, and age of onset.Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.Frequency, risk factors, and adverse sequelae of bone loss in patients with ostomy for inflammatory bowel diseases.Long-term development of bone geometry and muscle in pediatric inflammatory bowel disease.Rapid improvement of bone metabolism after infliximab treatment in Crohn's diseaseBody mass and composition affect bone density in recently diagnosed inflammatory bowel disease: The Manitoba IBD cohort studyAll Patients with Inflammatory Bowel Disease Should Have Bone Density Assessment: ConBones and Crohnʼs
P2860
Q28287175-13686227-F739-4932-93B2-A098260EC208Q28360089-EA3EE4EB-2B7F-40D5-B773-28B189297EB0Q33303194-C4401995-9165-4C7A-8E7B-5C9013242584Q33715512-9075E7A3-6493-4BA2-89E5-8EB92CD7268CQ33869248-AE47726D-E077-4E57-A450-18305646AA50Q35207986-B7D44394-566A-4D5C-BA8E-1F0C04AD054CQ35597297-6E60F652-72E3-4D67-95AB-3237CC5C6FDFQ35597889-4EE1476F-A9B8-43F2-A88F-5DE0D85F11A7Q35598252-7C6A435B-4802-4908-BDFD-F4E599DB01B1Q35858862-AAC84951-437D-4E67-8AD4-1C0BC667DCC6Q36133240-284C0507-6CAC-4424-BFD8-EFA319FBB64EQ36321697-435147A3-235F-4225-9F76-1CE0A6EF7E09Q36510678-5B4E9968-8B17-4F6C-8B90-CEE78F89FA38Q36569260-E7DAADAE-40B2-4BAE-BD30-5C715624B09CQ36609666-6B51BC53-088D-4139-99DE-C81418C3E823Q36635099-8DEA5E4D-7239-4F30-B21C-54A4C1A46FF4Q36737076-741A4FF0-7F8B-4FE4-A67A-07192B366537Q36761878-A6D9BC6E-1A08-4FC9-AC18-101623E860CCQ37136913-33487F4B-A309-46D5-877D-F758CAA7D0B5Q37609120-9BDC6159-770B-4D85-B695-9B22C64203DDQ37786310-50F1D7F9-A2D6-4EF1-941A-44F0BEF69883Q38223408-7CA768EB-DF37-4365-941D-C7502D9B6627Q38513477-F8A2AB77-7C84-4E89-A285-6398595CB9C5Q38609224-CBD1370A-4133-4A04-B2E8-A711EA30A687Q41740645-68E96CBE-FC98-4F7C-BFE1-CED5C80FC132Q42342936-583720FD-C153-499D-87A6-69D3EFFE70E0Q44113788-7EB452B5-AC26-4339-AFED-3974A6E37C85Q46959285-307D5CAD-C447-4D4B-A1BE-257666C67F21Q51750374-BEBA8DF8-1B54-4960-8451-90D9A6AFADABQ53097482-D534A474-37D6-4EA0-ACEF-66C8589ED8BBQ53250689-ECA1CF1F-263E-4255-B0B2-31F22C981E8CQ57265455-C3873130-91D2-4E5B-AC76-43B294331F4FQ57711701-6E555017-EFF2-45F0-A61E-01DB3496656DQ57711910-4696AD2F-239B-4EBB-8A65-627C0126DFB6Q59120553-1DB2FFF7-48A7-4EC6-A641-56DEA544FAB6
P2860
Osteoporosis and determinants of bone density in patients with Crohn's disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Osteoporosis and determinants of bone density in patients with Crohn's disease.
@en
Osteoporosis and determinants of bone density in patients with Crohn's disease.
@nl
type
label
Osteoporosis and determinants of bone density in patients with Crohn's disease.
@en
Osteoporosis and determinants of bone density in patients with Crohn's disease.
@nl
prefLabel
Osteoporosis and determinants of bone density in patients with Crohn's disease.
@en
Osteoporosis and determinants of bone density in patients with Crohn's disease.
@nl
P2093
P356
P1476
Osteoporosis and determinants of bone density in patients with Crohn's disease.
@en
P2093
Kryswcki T
Mayberry JF
Robinson RJ
al-Azzawi F
P2888
P304
P356
10.1023/A:1026650719552
P577
1998-11-01T00:00:00Z
P6179
1042236637